Current Affairs-Topics

Yeztugo HIV Injection

In a historic development in the fight against HIV, the United States Food and Drug Administration (US FDA) has approved Yeztugo HIV injectiona revolutionary drug for the long-acting prevention of HIV.

Manufactured by Gilead Sciences, Yeztugo, scientifically known as Lenacapavir injection, is a twice-yearly HIV shot shown to be 99.9% effective in Phase 3 clinical trials.

This update holds immense relevance for SSC and other government exam aspirantsparticularly in current affairs, science and technology, and health-related awareness.

What is Yeztugo HIV Injection?

Yeztugo HIV injection is the commercial name for Lenacapavir injection, a long-acting HIV prevention drug. What sets it apart is its biannual schedule, making it the first-ever HIV prevention injection taken just twice a year.

Key Features of Yeztugo HIV Injection:

  • Type: Injectable antiretroviral drug

  • Manufacturer: Gilead Sciences

  • Effectiveness: 99.9% in clinical trials

  • Schedule: Once every six months

  • Use: Prevents HIV infection before exposure

How Does It Work?

  • Unlike traditional oral PrEP drugs that require daily intake, Yeztugo HIV injection works by inhibiting the HIV capsid protein, preventing the virus from multiplying.

  • This makes Lenacapavir injection one of the most promising tools in the fight against HIV transmission.

The Yeztugo dosage and schedule involve just two subcutaneous injections per year, which significantly increases adherence among high-risk populations.

Clinical Trial Insights

  • In large-scale Phase 3 trials, Yeztugo HIV injection demonstrated near-total efficacy, outperforming many existing oral regimens.

  • Its strong results have fast-tracked regulatory approvals in various regions.

The US FDA HIV drug Yeztugo has already been lauded as a breakthrough injectable HIV prevention treatment, and its approval has global implications.

Importance of Global Health

  • The approval of Yeztugo HIV injection is a vital step in reducing the global HIV burden, especially in countries where daily medication adherence is low.

  • Health organizations and NGOs are pushing to introduce this latest HIV prevention medicine in Asia, Africa, and Latin America.

For aspirants preparing for SSC, UPSC, or State PSC exams, this falls under the category of global health and international cooperation in science and medicine.

Comparative Table: Yeztugo vs. Traditional PrEP

Feature

Yeztugo HIV Injection

Traditional PrEP Pills

Frequency

Twice a year

Daily

Type

Injection

Oral

Adherence Rate

High

Medium

Effectiveness

99.9%

~95%

Global Rollout Expected

2025–26

Already in use

What is Lenacapavir Injection?

  • Lenacapavir injection is the scientific term for the drug used in Yeztugo HIV injection.

  • It is a capsid inhibitor, meaning it blocks a crucial step in the HIV replication cycle, making it harder for the virus to multiply and infect the host.

Yeztugo Dosage and Schedule

Parameter

Detail

Brand Name

Yeztugo

Drug Type

Lenacapavir

Dose Frequency

Twice yearly

Administration

Subcutaneous injection

Purpose

HIV prevention

This biannual HIV protection shot has simplified HIV prevention strategies globally.

Additional Related Information for Exams

  • Yeztugo HIV injection can prevent new infections in high-risk populations.

  • It is expected to reduce healthcare costs by minimizing frequent medication.

  • Being a long-acting HIV prevention drug, it is particularly useful in remote or under-resourced areas.

  • Gilead Yeztugo's HIV drug may receive WHO pre-qualification for wider international adoption.

SSC Exam Takeaways

For SSC or government job aspirants, here are important points to remember:

  • Drug Name: Yeztugo

  • Generic Name: Lenacapavir

  • Type: HIV prevention injection

  • Approval Body: US FDA

  • Dosage: Twice a year

  • Effectiveness: 99.9%

  • Relevance: Public health, science, international development

Final Thoughts

The Yeztugo HIV injection marks a significant advancement in global HIV prevention, offering a convenient, long-acting solution with just two doses a year.

With its high effectiveness, simplified dosage schedule, and US FDA approval, Yeztugo sets a new standard for long-term HIV protection.

For SSC aspirants, this development is crucial from both a health and current affairs perspective, reflecting progress in medical innovation and global public health efforts.

More Related Articles

Russia Nuclear Readiness Test 2025

On 22 October 2025, Russia conducted a comprehensive nuclear readiness test, under the direct supervision of President Vladimir Putin, involving strategic missile launches from land, sea, and air.

NZ Social Media Ban 2025

In a significant move reflecting growing global concerns about teen mental health and online safety, New Zealand is set to debate legislation that would restrict social media access for children u

Tuvalu Biodiversity Overview

The Government of Tuvalu has officially joined the International Union for Conservation of Nature (IUCN) as its 90th State Member. This significant development highlights the growing global attent

Middle East Peace Effort 2025

The Middle East peace effort 2025 has taken a historic turn with former US President Donald Trump being recognised for his pivotal role in mediating a ceasefire between Israel and Hamas. Israeli P

Historic Rise of Sanae Takaichi

In a historic moment for Japanese politics, Sanae Takaichi has been elected as Japan’s first female prime minister, breaking one of the country’s most enduring political glass ceilings

India Mongolia Relations Explained

The President of Mongolia recently undertook a state visit to India, commemorating the 70th anniversary of diplomatic relations and the 10th anniversary of the India-Mongolia strategic partne

India-China Visa Services Across China

In a major development strengthening India-China diplomatic ties, BLS International Services Ltd has been awarded a three-year contract by India’s Ministry of External Affairs (MEA) to estab

World Food Day 2025

World Food Day 2025, observed on 16 October, is a significant occasion that draws global attention to the challenges of food security, nutrition awareness, and sustainable agriculture. The the

SDG Zero Hunger 2030

The SDG Zero Hunger 2030 is one of the 17 Sustainable Development Goals set by the United Nations to ensure that no one suffers from hunger and malnutrition by 2030. Despite global efforts, the wo

Maitri II Antarctica

India is set to expand its scientific presence in Antarctica with the approval of Maitri II Antarctica, a new research station planned in eastern Antarctica. The Finance Ministry has sanctioned a

Toppers

anil kumar
Akshay kuamr
geeta kumari
shubham